A CMOS-Based Bidirectional Brain Machine Interface System With Integrated fdNIRS and tDCS for Closed-Loop Brain Stimulation

Frequency-domain instrument with custom ASIC for dual-slope near-infrared spectroscopy

Real-time and non-invasive measurements of tissue concentrations of oxyhemoglobin (HbO2) and deoxyhemoglobin (HbR) are invaluable for research and clinical use. Frequency-domain near-infrared spectroscopy (FD-NIRS) enables non-invasive measurement of these chromophore concentrations in human tissue. We present a small form factor, dual-wavelength, miniaturized FD-NIRS instrument for absolute optical measurements, built around a custom application-specific integrated circuit and a dual-slope/self-calibrating (DS/SC) probe. The modulation frequency is 55 MHz, and the heterodyning technique was used for intensity and phase readout, with an acquisition rate of 0.7 Hz. The instrument consists of a 14 × 17 cm2 printed circuit board (PCB), a Raspberry Pi 4, an STM32G491 microcontroller, and the DS/SC probe. The DS/SC approach enables this instrument to be selective to deeper tissue and conduct absolute measurements without calibration. The instrument was initially validated using a tissue-mimicking solid phantom, and upon confirming its suitability for in vivo, a vascular occlusion experiment on a human subject was conducted. For the phantom experiments, an average of 0.08° phase noise and 0.10% standard deviation over the mean for the intensities was measured at a source-detector distance of 35 mm. The absorption and reduced scattering coefficients had average precisions (variation of measurement over time) of 0.5% and 0.9%, respectively, on a window of ten frames. Results from the in vivo experiment yielded the expected increase in HbO2 and HbR concentration for all measurement types tested, namely SC, DS intensity, and DS phase.

Review of recent advances in frequency-domain near-infrared spectroscopy technologies [Invited]

Over the past several decades, near-infrared spectroscopy (NIRS) has become a popular research and clinical tool for non-invasively measuring the oxygenation of biological tissues, with particular emphasis on applications to the human brain. In most cases, NIRS studies are performed using continuous-wave NIRS (CW-NIRS), which can only provide information on relative changes in chromophore concentrations, such as oxygenated and deoxygenated hemoglobin, as well as estimates of tissue oxygen saturation. Another type of NIRS known as frequency-domain NIRS (FD-NIRS) has significant advantages: it can directly measure optical pathlength and thus quantify the scattering and absorption coefficients of sampled tissues and provide direct measurements of absolute chromophore concentrations. This review describes the current status of FD-NIRS technologies, their performance, their advantages, and their limitations as compared to other NIRS methods. Significant landmarks of technological progress include the development of both benchtop and portable/wearable FD-NIRS technologies, sensitive front-end photonic components, and high-frequency phase measurements. Clinical applications of FD-NIRS technologies are discussed to provide context on current applications and needed areas of improvement. The review concludes by providing a roadmap toward the next generation of fully wearable, low-cost FD-NIRS systems.

Functional Near-Infrared Spectroscopy as a Personalized Digital Healthcare Tool for Brain Monitoring

The sustained growth of digital healthcare in the field of neurology relies on portable and cost-effective brain monitoring tools that can accurately monitor brain function in real time. Functional near-infrared spectroscopy (fNIRS) is one such tool that has become popular among researchers and clinicians as a practical alternative to functional magnetic resonance imaging, and as a complementary tool to modalities such as electroencephalography. This review covers the contribution of fNIRS to the personalized goals of digital healthcare in neurology by identifying two major trends that drive current fNIRS research. The first major trend is multimodal monitoring using fNIRS, which allows clinicians to access more data that will help them to understand the interconnection between the cerebral hemodynamics and other physiological phenomena in patients. This allows clinicians to make an overall assessment of physical health to obtain a more-detailed and individualized diagnosis. The second major trend is that fNIRS research is being conducted with naturalistic experimental paradigms that involve multisensory stimulation in familiar settings. Cerebral monitoring of multisensory stimulation during dynamic activities or within virtual reality helps to understand the complex brain activities that occur in everyday life. Finally, the scope of future fNIRS studies is discussed to facilitate more-accurate assessments of brain activation and the wider clinical acceptance of fNIRS as a medical device for digital healthcare.

Novel Non-invasive Transcranial Electrical Stimulation for Parkinson's Disease

Conventional transcranial electrical stimulation (tES) is a non-invasive method to modulate brain activity and has been extensively used in the treatment of Parkinson's disease (PD). Despite promising prospects, the efficacy of conventional tES in PD treatment is highly variable across different studies. Therefore, many have tried to optimize tES for an improved therapeutic efficacy by developing novel tES intervention strategies. Until now, these novel clinical interventions have not been discussed or reviewed in the context of PD therapy. In this review, we focused on the efficacy of these novel strategies in PD mitigation, classified them into three categories based on their distinct technical approach to circumvent conventional tES problems. The first category has novel stimulation modes to target different modulating mechanisms, expanding the rang of stimulation choices hence enabling the ability to modulate complex brain circuit or functional networks. The second category applies tES as a supplementary intervention for PD hence amplifies neurological or behavioral improvements. Lastly, the closed loop tES stimulation can provide self-adaptive individualized stimulation, which enables a more specialized intervention. In summary, these novel tES have validated potential in both alleviating PD symptoms and improving understanding of the pathophysiological mechanisms of PD. However, to assure wide clinical used of tES therapy for PD patients, further large-scale trials are required.

Light Modulation of Brain and Development of Relevant Equipment

Light modulation plays an important role in understanding the pathology of brain disorders and improving brain function. Optogenetic techniques can activate or silence targeted neurons with high temporal and spatial accuracy and provide precise control, and have recently become a method for quick manipulation of genetically identified types of neurons. Photobiomodulation (PBM) is light therapy that utilizes non-ionizing light sources, including lasers, light emitting diodes, or broadband light. It provides a safe means of modulating brain activity without any irreversible damage and has established optimal treatment parameters in clinical practice. This manuscript reviews 1) how optogenetic approaches have been used to dissect neural circuits in animal models of Alzheimer's disease, Parkinson's disease, and depression, and 2) how low level transcranial lasers and LED stimulation in humans improves brain activity patterns in these diseases. State-of-the-art brain machine interfaces that can record neural activity and stimulate neurons with light have good prospects in the future.